DrugInfoSys

Etoricoxib

Drug #1795

Etoricoxib is a non-steroidal anti-inflammatory drug (NSAIDs). Etoricoxib is a selective inhibitor of cyclo-oxygenase-2 and is used for the symptomatic relief of pain and inflammation in osteoarthritis, rheumatoid arthritis and acute gout.

Primary Characteristics

Molecular Weight: 358.84 · Non-proprietary name: Etoricoxib.

Molecular structure of Etoricoxib

Pharmacokinetics

Distribution: Etoricoxib has a plasma protein binding is 92%.

Elimination: it is metabolised via Hepatic CYP extenswely involved, plasma half-life is 22 hrs, renal excretion is 70% & fecal 20%.

Advertisement

Indications

Contraindications

Etoricoxib is contraindicated in conditions like Uncontrolled hypertension.

Dosage

Etoricoxib's dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
60 mg60 mgEvery 24hPOFor Arthritis, osteoarthritis
90 mg90 mgEvery 24hPOFor Rheumatoid arthritis:
120 mg120 mgEvery 24hPOFor Acute gouty arthritis:
120 mg120 mgEvery 24hPOForAnalgesia, Acute pain associated with dental surgery:
Paediatric Dosage (20kg)
No data.
Neonatal Dosage (3kg)
No data.

Drug Interactions

None recorded.

Side Effects

Etoricoxib is known to cause more or less tolerable side effects which are usually transient. These include Angioedema, Depression, Diarrhea, Drowsiness, Fever, GI bleeding, Headache, Hypersensitivity , Nausea, Peptic ulteration, Vertigo, Vomiting .

Warnings / Precautions

Available Brands

Click on a strength to view available brands.

Single Ingredient

Tabs

Storage Conditions

Etoricoxib should be stored .

Drug Classification

  1. 1.2.1.3Non steroidal anti-inflammatory drugs (NSAIDs)

Manufacturers

Manufacturers of Etoricoxib in Pakistan: